Trials / Enrolling By Invitation
Enrolling By InvitationNCT06736769
Ketamine Effects on Learning In Eating Disorders
"KETTLE" Trial: Ketamine Effects on Learning In Eating Disorders
- Status
- Enrolling By Invitation
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Amanda Downey, MD · Academic / Other
- Sex
- All
- Age
- 16 Years – 26 Years
- Healthy volunteers
- Not accepted
Summary
This is a single site, single dose clinical trial of intravenous (IV) ketamine for medically hospitalized adolescents and young adults with anorexia nervosa or atypical anorexia nervosa. Eating disorder symptoms will be measured pre- and post-ketamine infusion. Investigators hypothesize that ketamine will increase cognitive flexibility, making medical hospitalizations less distressing by improving the ability to learn new, positive associations with food.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine infusion | Ketamine will be delivered intravenously at 0.5 mg/kg over 40 minutes. |
Timeline
- Start date
- 2025-06-05
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2024-12-17
- Last updated
- 2025-06-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06736769. Inclusion in this directory is not an endorsement.